6 news items
Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024
GUTS
20 May 24
, Chief Financial Officer ir@fractyl.com, 781.902.8800 Media Contact Beth Brett, Corporate Communications bbrett
Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates
GUTS
13 May 24
@fractyl.com, 781.902.8800 Media ContactBeth Brett, Corporate Communications
Fractyl Health Presents Clinical Update on Revita® German Real-World Registry for Patients With Advanced Type 2 Diabetes (T2D)
GUTS
13 May 24
Media ContactBeth Brett, Corporate Communications
Fractyl Health to Present at BofA Securities 2024 Health Care Conference
GUTS
8 May 24
Beth Brett, Corporate Communications
Fractyl Health to Report First Quarter 2024 Financial Results and Provide Business Updates on May 13, 2024
GUTS
7 May 24
Communications
sm1ni03js1ka3p5jo4csbvwvhkos5xlillie91l0hzxi9zn5nwm1fx1
GUTS
30 Apr 24
, 781.902.8800 Media Contact Beth Brett, Corporate Communications
- Prev
- 1
- Next